Related Experiment Video
Updated: Feb 15, 2026

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
B B Brodey1, R R Girgis2, O V Favorov3
1TeleSage, Inc., 201 East Rosemary St., Chapel Hill, NC 27514, USA.
Machine learning identified key early psychosis self-report items, creating a 26-item screener (EPS-26). This new tool effectively differentiates individuals at clinical high risk (CHR) for psychosis, potentially reducing untreated psychosis duration.
Area of Science:
- Psychiatry and Mental Health
- Machine Learning Applications
- Clinical Psychology
Background:
- Early psychosis detection is crucial for intervention and improving outcomes.
- Current screening methods may have limitations in accessibility or efficiency.
- Identifying individuals at clinical high risk (CHR) is a key step in early intervention.
Purpose of the Study:
- To develop and validate a self-report early psychosis screener (EPS) using machine learning.
- To identify highly informative self-report items for early psychosis detection.
- To compare the performance of the developed screener against existing measures and clinician-administered tools.
Main Methods:
- Machine learning, including spectral clustering and Minimum Redundancy Maximum Relevance, was applied to a large item pool.
- Data were collected from 229 individuals screened using the Structured Interview for Psychosis-risk Syndromes (SIPS).
- A 26-item Early Psychosis Screener (EPS-26) was developed and its performance evaluated using receiver operating characteristic analysis.
Main Results:
- Machine learning identified two item groups related to psychosis/mania and depression/anxiety/functioning.
- The 26-item EPS demonstrated high accuracy (AUC=0.899) in differentiating clinically low risk (CLR) from CHR individuals.
- The EPS-26 outperformed the Prodromal Questionnaire-Brief Version (PQ-B) (AUC=0.834) and showed comparable performance to the clinician-administered SIPS.
Conclusions:
- The self-report EPS-26 is a promising tool for screening individuals at risk for psychosis.
- This screener may aid in reducing the duration of untreated psychosis.
- Further validation against actual conversion to psychosis is ongoing.
More Related Videos
Related Concept Videos
Reliability and Validity
EPS and iPS Cells in Disease Research
Psychosis: Goals of Pharmacotherapy
Machines
A free-body diagram of the...
Psychosis and Antipsychotic Drugs: Overview
Machines: Problem Solving II

